Morning all!

Arena Events ( £ARE ) – 28p – £43m – PER 7

Interim Results For The 6 Months To End June 2019 – Satisfactory H1, H2 weighting and year end changed to March.

I don’t really like anything in this update and am finally going to cease coverage here.

Anexo ( £ANX ) – 192p – £211m – PER 11

Interim Results For The 6 Months To End June 2019 – Strong H1 growth and confident in meeting current market expectations for the FY.

Still looks quite reasonable but do not particularly like (fully understand) the nature of the business – So, it’s not for me. Actually I will now cease coverage.

Boku Inc ( £BOKU ) – 102p – £255m – PER 115

Interim Results For The 6 Months To End June 2019 – Good H2 required and perhaps expected.

I am Long here and, subject to market reaction, this update will not give me reason to change that at present. I would of course have preferred not to have a H2 weighting.

Concurrent Technologies ( £CNC ) – 63p – £46m – PER 10

Interim Results For The 6 Months To End June 2019 – Strong H1 with record Order Book, guides that it expects to deliver a successful performance for the FY.

I still see this as priced about right and would like to have seen an against expectations statement here rather than a “successful performance”.

EKF Diagnostics ( £EKF ) – 31p – £141m – PER 22

Interim Results For The 6 Months To End June 2019 – Earnings ahead of management expectations, Q3 trading in-line.

Looks like a good update but forecasts here reflect all round single digit growth this year and next so although ROCE and Operating Margin are great – Doesn’t seem like much value to me at this level.

Midwich ( £MIDW ) – 500p – £400m – PER 16

Interim Results For The 6 Months To End June 2019 – Strong H1 gives the board confidence but does not guide on FY.

Still not interested but 480p could perhaps be a bottom here.

Team17 ( £TM17 ) – 302p – £396m – PER 32

Interim Results For The 6 Months To End June 2019 – Revenue up 97%, Adjusted EBITDA up 145% and EPS up 356%, Cash at £35.8m (£16.7m). Comfortable…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here